Skip to content
  • 6,803 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Award notice, first published as sources sought

Notice of Intent to Sole Source Biofire Global Fever Test Kits at U.S. Naval Hospital Okinawa, Japan

HT941024N0092

Defense Health Agency (Dha), Defense Health Agency HCD West. In-Vitro Diagnostic Substance Manufacturing.

Awarded

Biofire Defense LLC

$38,820.00 on the award notice, July 11, 2024, contract HT941024P0187

Get the next one like this from Defense Health Agency (Dha) by email, the day it is posted.Find my opportunities

This one was awarded in 2024

13 like it are open now in in-vitro diagnostic substance manufacturing

All 13 open in in-vitro diagnostic substance manufacturing

Description

As published on SAM.gov.

The Defense Health Agency, Contracting Office - San Diego (HT9410), 7700 Arlington Blvd., Falls Church, VA 22042, has awarded a firm-fixed price (FFP), supply contract. The supplies provide BioFire Global Fever Special Pathogens Panel IVD, 6 Test (27 PG), and BioFire Shield Control Kit for GFSPP, 12 controls (2 PG). at U.S. Naval Hospital Okinawa, Japan. This sole source and firm-fixed price contract was awarded to Biofire Defense LLC on 11 July 202 for a one-time purchase base and no option pedriods.

Total contract value is $38,820.00. Biofire Defense LLC is the Original Equipment Manufacturer (OEM) of the BioFire Global Fever Special Pathogens Panel and BioFire Shield Control Kits. BioMérieux is the parent company.

However, BioFire Defense was created specifically to retain confidentiality of U.S. Government strategic assets under the Foreign Ownership Control and Influence (FOCI) mitigation agreement between the US Government, BioFire Defense (BFDF), BioMérieux, and all Affiliate companies owned by BioMérieux.

Because of this and its corresponding MOU, all US Department of Defense accounts fall solely under BioFire Defense LLC. Additionally, BioMérieux does not have authorization to sell the Global Fever Special Pathogens Test kits or Global Fever Special Pathogens SHIELD control kits. These kits are only available to be ordered through BioFire Defense. The second part of the Sole Source letter specifies that BioFire is the sole provider, and not BioMérieux.

The contract, on USAspending

Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.

UEI
NHMDGM122546
CAGE
088J2
Vendor location
Salt Lake City, UT
Contract
HT941024P0187, purchase order
Obligated
$38,820.00
Actions
1 between July 11, 2024 and July 11, 2024
Competition
Not Competed Under SAP, 1 offer received
Set-aside reported
No Set Aside Used.
Described as
Biofire Global Fever Special Pathogens Tests
Match
award number HT941024P0187 equals the contract number; same awarding office HT9410 (high confidence)

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 1, 2024

    Sources sought

    Due July 5, 2024 at 1:00 PM EDT. SAM.gov, notice 9dc1e6226c1b4885897a749f7fc4e834

  2. July 12, 2024

    Award notice

    Awarded to BIOFIRE DEFENSE LLC Salt Lake City for $38,820. SAM.gov, notice 3a963717a26e47c886e6adb7073b9728

Points of contact